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Volume 51, Number 11S Abstracts 43SMethods: A retrospective chart review showed 5 pa-
tients (1 in 1992, 4 since 2004) underwent vertebral to
common carotid transpositions. A systematic search for all
studies that evaluated VA interventions was done through
MEDLINE and bibliographic search. Various demo-
graphic and endpoint variables were extracted.
Results: Our case series comprises 5 patients (mean age:
75.4 years, M:F 4:1, symptomatic 100%). Shunts were used in
two cases. We had no wound complications or postoperative
morbidity. The mean follow was 23.8 months with no stroke/
TIAs and100%patencyonDoppler.Onepatientdied from lung
cancer 4 years after surgery and one 6 years after surgery from
unknown causes. 30 studies on VA stenting and/or angio-
plasty were identified (1981-2009). There were 8 studies
describing surgery (1984-2000). Following surgical treat-
ment, lower rates of restenosis (2.3%) were seen with longer
follow-up, but wound complications were relatively com-
mon. Restenosis was a problem after stent placement with
no difference between bare metal (27.7%) or drug eluting
stents (26.1%). The duration of follow-up and presence of
bilateral VA disease was significantly associated with reste-
nosis on regression analysis. Unexpectedly, degree of ste-
nosis was inversely related to degree of initial stenosis.
Conclusions: Surgery and endovascular interventions
have good initial technical success. Restenosis is problem-
atic with bare metal or drug-eluting stents. Surgery is
associated with a higher risk of wound complications but
provides superior longterm results.
Author Disclosures: S. Arya: Nothing to disclose; B. T.
Baxter: Nothing to disclose; I. Pipinos: Nothing to dis-
close; E. A. Waltke: Nothing to disclose; S. P. Watten-
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Objectives: Scheduling of CEA in symptomatic carotid
artery stenosis (SCAS) remains controversial. No consensus
exists on management of crescendo TIAs (cTIA) or SIE.
We endeavour to evaluate 5-year survival rates and freedom
from stroke in patients with SCAS14days, cTIA and SIE.
Methods: Between 2002- 2008, 1847 patients were ap-
praisedwith carotid stenosis60%.ThePredicted Probability of
Receiving intervention was tabulated for all Patients by Using
Multiple Logistic Regressions to Control for Co-morbidity and
Anatomical High-risk Factors. Mean age was similar between
SCAS, 68.6 years and cTIA, 69.1 years (p0.05) but SIE pa-
tients were younger (67.2 years) than SCAS (p  0.01) or
CTIAS (p  0.05). SVS co-morbidity scores were similar
between groups (p  0.05). SCAS were less likely to haveecholucent plaque on duplex US (p  0.001). Fast Track
Clear Pathway Permitted rapid Triage and Management.
Results: Over all Death/stroke rate was 1.9% (Table
1). Compared to SCAS (87.9%) 5-year stoke-free survival
was not distinctive for cTIA (93.3%, p  0.818) or SIE
(92.9%, p  0.184). 5-year intervention free survival was
not diverse with SCAS (87%) compared to cTIA (91.1%,
p  0.889) or SIE (92.9%, p  0.231).
Conclusions: Indications for Emergency CEA are Li-
tigious. The menace of CEA is Drastically Higher in Neu-
rologically Unstable patients. Conversely Natural History
of Acute Carotid occlusion Without Surgery is Atrocious.
Emergency Surgery should be Indicated if it Propounds
Improved Outcomes Over Aggressive Medical Therapy.
Table 1
Symptomatic
14 days
Crescendo
TIAs
Stroke in
Evolution P Value
Number 359 300 (83.5%) 45 (12.5%) 14.4%
Stroke 2 (0.67%) 1 (2.2%) 1 (7.1%) 0.059
Death 2 (0.67%) 1 (2.2%) 0 (0%) 0.533
Author Disclosures: N. Hynes: Nothing to disclose; S.
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Transradial Approach for the Treatment of Non-ma-
turing Hemodialysis Fistulae May Have Better Patency
Than Standard Direct Fistula Approach
Alessandro Smeraldi, Samir Pancholy, Jason Butchko.
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Objectives: Percutaneous angioplasty of non-matured
proximal arm hemodialysis arteriovenous fistulae presents a
unique challenge given the frequently non-arterialized vein
and the awkward working angle. We describe our results
using a transradial artery approach.
Methods: All patients with proximal arm fistulae who
underwent percutaneous angioplasty between July 2007 and
July 2009 were included. The primary endpoints were tech-
nical success, successful cannulation and time required for
maturation. Data were retrospectively collected and analyzed.
Results: A total of 32 consecutive procedures were
performed in 25 patients with non-maturing brachioce-
phalic or brachiobasilic fistulae. Balloon angioplasty matu-
ration was accomplished either by a radial artery approach
(RABAM) or by a standard direct fistula approach (BAM).
The RABAM study group included 14 procedures in 11
patients and the control BAM group included 18 proce-
dures in 14 patients. Patients were followed for a mean of
9.2  8.4 months. Technical success was 100% in both
groups. Four patients, two in each group, died before they
could start dialysis. Successful cannulation was achieved
more frequently in the study group (RABAM, 77.8%;
BAM, 50%). The mean time to cannulation was shorter in
the study group (RABAM, 35.7  22.7 days; BAM,
87.5  68.7 days; p 0.05). Complications were few; one
asymptomatic radial artery thrombosis and one minor he-
